Current Signal Transduction Therapy (CSTT)

Current Signal Transduction Therapy is an international peer‑reviewed journal that disseminates cutting‑edge research and authoritative reviews on signal transduction and its therapeutic applications. Established in 2006, the journal recognizes that dysregulated cellular signaling underlies many pathologies — including cancer, neurodegenerative disorders, inflammation, and metabolic syndrome — and that effective therapies increasingly depend on understanding and modulating these pathways. Published quarterly by Bentham Science Publishers, the journal emphasizes both basic molecular insights and clinical translational studies. It includes timely in‑depth reviews of current concepts in signaling biology, original research articles presenting new experimental or clinical data, and reports on drug discovery and clinical trials targeting signaling nodes. The journal also publishes thematic issues that focus on emerging topics such as kinase inhibitors, receptor modulators, transcriptional regulators, and signaling dynamics in disease progression. Its interdisciplinary coverage spans genomics and proteomics, medicinal chemistry, and cell biology, providing a broad platform for scientists working at the interface of signal transduction and therapeutic innovation. By bridging fundamental mechanisms with clinical relevance, Current Signal Transduction Therapy supports the development of novel treatments and enhances understanding of how signaling networks drive pathology and responses to intervention.

Current Signal Transduction Therapy (CSTT) is :-

• International, Peer-Reviewed, Open Access, Refereed, Communication, Fundamental mechanisms of signal transduction biology in health and disease., Translational and therapeutic research on signaling pathways in cancer, neurodegeneration, Original research articles, comprehensive reviews, clinical trial reports related to drug modulation of key signaling networks , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1574-3624, E-ISSN: 2212-389X, Established: 2007,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE